Abstract
Background
Regional citrate anticoagulation (RCA) is the preferred modality of anticoagulation used in continuous kidney replacement therapy (CKRT) in adults and less extensively in children. Potential metabolic complications limit widespread use in infants, neonates, and in children with liver failure.
Methods
We report our experience with a simplified protocol in 50 critically ill children, infants, and neonates, some of them with liver failure, with commercially available solutions containing phosphorous and higher concentration of potassium and magnesium.
Results
RCA allowed attainment of a mean filter lifetime of 54.5 ± 18.2 h, 42.5% of circuits lasted more than 70 h, and scheduled change was the most frequent cause of CKRT interruption. Patient Ca++ and circuit Ca++ were maintained in the target range with mean values of 1.15 ± 0.13 mmol/l and 0.38 ± 0.07 mmol/l, respectively. No session had to be stopped because of metabolic complications. The most frequent complications were hyponatremia, hypomagnesemia, and metabolic acidosis mostly related to primary disease and critical illness. No session had to be stopped because of citrate accumulation (CA). Transitory CA occurred in 6 patients and was managed without requiring RCA interruption. No patients with liver failure presented CA episodes.
Conclusions
In our experience, RCA with commercially available solutions was easily applied and managed in critically ill children, even in patients with low weight or with liver failure. Solutions containing phosphate and higher concentrations of magnesium and potassium allowed reduction of metabolic derangement during CKRT. Prolonged filter life was ensured with no detrimental effects on patients and reduced staff workload.
Graphical abstract
Similar content being viewed by others
Data availability
The datasets generated and analyzed during the current study are available from the corresponding author on request.
References
Kaddourah A, Basu RK, Bagshaw SM, Goldstein SL, AWARE Investigators (2017) Epidemiology of acute kidney injury in critically Ill children and young adults. N Engl J Med 376:11–20. https://doi.org/10.1056/NEJMoa1611391
Chanchlani R, Nash DM, McArthur E, Zappitelli M, Archer V, Kowornu JP, Garg AX, GreenbergJH, Goldstein SL, Thabane L, Wald R (2019) Secular trends in incidence, modality, and mortality with dialysis receiving aki in children in Ontario. A Population-Based Cohort Study. Clin J Am Soc Nephrol 14:1288–1296. https://doi.org/10.2215/CJN.08250718
Guzzo I, De Galasso L, Mir S, Bulut IK, Jankauskiene A, Burokiene V, Cvetkovic M, Kostic M, Bayazit AK, Yildizdas D, Schmitt CP, Paglialonga F, Montini G, Yilmaz E, Oh J, Weber L, Taylan C, Hayes W, Shroff R, Vidal E, Murer L, Mencarelli F, Pasini A, Teixeira A, Afonso AC, Drozdz D, Schaefer F, Picca S, ESCAPE Network (2019) Acute dialysis in children: results of a European survey. J Nephrol 32:445–451. https://doi.org/10.1007/s40620-019-00606-1
Goldstein SL (2011) Advances in pediatric renal replacement therapy for acute kidney injury. Semin Dial 24:187–191. https://doi.org/10.1111/j.1525-139X.2011.00834.x
De Galasso L, Guzzo I, Picca S (2020) Dialysis modalities for the management of pediatric acute kidney injury. Pediatr Nephrol 35:753–765. https://doi.org/10.1007/s00467-019-04213-x
Raina R, Chakraborty R, Davenport A, Brophy P, Sethi S, McCulloch M, Bunchman T, Yap HK (2021) Anticoagulation in patients with acute kidney injury undergoing kidney replacement therapy. Pediatr Nephrol 37:2303–2330. https://doi.org/10.1007/s00467-021-05020-z
Legrand M, Tolwani A (2021) Anticoagulation strategies in continuous renal replacement therapy. Semin Dial 34:416–422. https://doi.org/10.1111/sdi.12959
Kidney disease: Improving global outcomes (KDIGO) (2012) Acute Kidney Injury Work Group. KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney Int Suppl 2:1–138
Morabito S, Pistolesi V, Tritapepe L, Fiaccadori E (2014) Regional citrate anticoagulation for RRTs in critically ill patients with AKI. Clin J Am Soc Nephrol 9:2173–2188. https://doi.org/10.2215/CJN.01280214
Bai M, Zhou M, He L, Ma F, Li Y, Yu Y, Wang P, Li L, Jing R, Zhao L, Sun S (2015) Citrate versus heparin anticoagulation for continuous renal replacement therapy: an updated meta-analysis of RCTs. Intensive Care Med 41:1098–2110. https://doi.org/10.1007/s00134-015-4099-0
Liu C, Mao Z, Kang H, Hu J, Zhou F (2016) Regional citrate versus heparin anticoagulation for continuous renal replacement therapy in critically ill patients: a meta-analysis with trial sequential anlysis of randomized controlled trials. Crit Care 20:144–157. https://doi.org/10.1186/s13054-016-1299-0
Meersch M, Kullmar M, Wempe C, Milles DK, Kluge S, Slowinski T, Marx G, Gerss J, Zarbock A, SepNet Critical Care Trials Group (2019) Regional citrate versus systemic heparin anticoagulation for continuous renal replacement therapy in critically ill patients with acute kidney injury (RICH) trial: study protocol for a multicentre randomized controlled trial. BMJ 9:e024411. https://doi.org/10.1136/bmjopen-2018-024411
Bunchman TE, Maxvold NJ, Barnett J, Hutchings A, Benfield MR (2002) Pediatric hemofiltration: Normocarb dialysate solution with citrate anticoagulation. Pediatr Nephrol 17:150–154. https://doi.org/10.1007/s00467-001-0791-0
Chadha V, Garg U, Warady BA, Alon US (2002) Citrate clearance in children receiving continuous veno-venous renal replacement therapy. Pediatr Nephrol 17:819–824. https://doi.org/10.1007/s00467-002-0963-6
Bunchman TE, Maxvold NJ, Brophy PD (2003) Pediatric convective hemofiltration: normocarb replacement fluid and citrate anticoagulation. Am J Kidney Dis 42:1248–1252. https://doi.org/10.1053/j.ajkd.2003.08.026
Elhanan N, Skippen P, Nuthall G, Krahn G, Seear M (2004) Citrate anticoagulation in pediatric continuous venovenous hemofiltration. Pediatr Nephrol 19:208–212. https://doi.org/10.1007/s00467-003-1328-5
Musielak A, Warzywoda A, Wojtalik M, Kocinski B, Kroll P, Ostalska-Nowicka D, Zachwieja J (2016) Outcomes of continuous renal replacement therapy with regional citrate anticoagulation in small children after cardiac surgery: experience and protocol from a single center. Ther Apher Dial 20:639–644. https://doi.org/10.1111/1744-9987.12456
Rajasekaran S, Jones DP, Avent Y, Shaffer ML, Elbahlawan L, Henderson N, Barfield RC, Morrison RR, Tamburro RF (2010) Outcomes of hematopoietic stem cell transplant patients who received continuous renal replacement therapy in a pediatric oncology intensive care unit. Pediatr Crit Care Med 11:699–706. https://doi.org/10.1097/PCC.0b013e3181e32423
Liet JM, Allain-Lamay E, Gaillard-LeRoux B, Barriere F, Chenouard A, Dejode JM, Joram N (2014) Regional citrate anticoagulation for pediatric CRRT using integrated citrate software and physiological sodium concentration solutions. Pediatr Nephrol 29:1625–2163. https://doi.org/10.1007/s00467-014-2770-2
Persic V, VajdicTrampuz B, Medved B, Pavcnik M, Ponikvar R, Gubensek J (2019) Regional citrate anticoagulation for continuous renal replacement therapy in newborns and infants: Ficus on citrate accumulation. Artif Organs 44:497–503. https://doi.org/10.1111/aor.13619
Rodriguez K, Srivaths PR, Tal L, Watson MN, Riley AA, Himes RW, Desal MS, Braun MC, Akcan Arikan A (2017) Regional citrate anticoagulation for continuous renal replacement therapy in pediatric patients with liver failure. PLoS One 12:e0182134. https://doi.org/10.1371/journal.pone.0182134
Nalesso F, Garzotto F, Cattarin L, Innico G, Gobbi L, Calò LA (2021) Impact of different hemodiafiltration solutions on ionemia in long-term CRRT. Int J Artif Organs 44:807–815. https://doi.org/10.1177/03913988211043203
Santiago MJ, López-Herce J, Urbano J, Bellón JM, del Castillo J, Carrillo A (2009) Hypophosphatemia and phosphate supplementation during continuous renal replacement therapy in children. Kidney Int 75:312–316. https://doi.org/10.1038/ki.2008.570
Pistolesi V, Zeppilli L, Fiaccadori E, Regolisti G, Tritapepe L, Morabito S (2019) Hypophosphatemia in critically ill patients with acute kidney injury on renal replacement therapies. J Nephrol 32:895–908. https://doi.org/10.1007/s40620-019-00648-5
Di Mario F, Regolisti G, Greco p, Maccari C, Superchi E, Morabito S, Pistolesi V, Fiaccadori E (2021) Prevention of hypomagnesemia in critically ill patients with acute kidney injuryon continuous kidney replacement therapy: the role of early supplementation and close monitoring. J Nephrol 34:1271-1279.https://doi.org/10.1007/s40620-020-00864-4
Khwaja A (2012) KDIGO Clinical Practice Guidelines for Acute Kidney Injury. Nephron Clin Pract 120:179–184
Jetton JG, Askenazi DJ (2012) Update on acute kidney injury in the neonate. Curr Opin Pediatr 24:191–196. https://doi.org/10.1097/MOP.0b013e32834f62d5
Goldstein B, Giroir B, Randolph A (2005) International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med 6:2–8. https://doi.org/10.1097/01.PCC.0000149131.72248.E6
Pollack MM, Patel KM, Ruttimann UE (1996) PRISM III: an updated pediatric risk of mortality score. Crit Care Med 24:743–752
Raina R, Sethi S, Khooblall A, Kher V, Deshpande S, Yerigeri K, Pandya A, Nair N, Datla N, McCulloch M, Bunchman T, Davenport A (2022) Non-anticoagulation pediatric continuous renal replacement therapy methods to increase circuit life. Hemodial Int 26:147–159. https://doi.org/10.1111/hdi.13003
Miklaszewska M, Korohoda P, Zachwieja K, Kobylarz K, Stefanidis CJ, Sobczak A, Drożdż D (2017) Filter size not the anticoagulation method is the decisive factor in continuous renal replacement therapy circuit survival. Kidney Blood Press Res 42:327–337. https://doi.org/10.1159/000477609
Ronco C, Garzotto F, Brendolan A, Zanella M, Bellettato M, Vedovato S, Chiarenza F, Ricci Z, Goldstein SL (2014) Continuous renal replacement therapy in neonates and small infants: development and first-in-human use of a miniaturised machine (CARPEDIEM). Lancet 383:1807–1813. https://doi.org/10.1016/S0140-6736(14)60799-6
Coulthard MG, Crosier J, Griffiths C, Smith J, Drinnan M, Whitaker M, Beckwith R, Matthews JN, Flecknell P, Lambert HJ (2014) Haemodialysing babies weighing <8 kg with the Newcastle infant dialysis and ultrafiltration system (Nidus): comparison with peritoneal and conventional haemodialysis. Pediatr Nephrol 29:1873–1881. https://doi.org/10.1007/s00467-014-2923-3
Askenazi D, Ingram D, White S, Cramer M, Borasino S, Coghill C, Dill L, Tenney F, Feig D, Fathallah-Shaykh S (2016) Smaller circuits for smaller patients: improving renal support therapy with Aquadex. Pediatr Nephrol 31:853–860. https://doi.org/10.1007/s00467-015-3259-3
Goldstein SL, Vidal E, Ricci Z, Paglialonga F, Peruzzi L, Giordano M, Laforgia N, Ronco C (2022) Survival of infants treated with CKRT: comparing adapted adult platforms with Carpediem. Pediatr Nephrol 37:667–675. https://doi.org/10.1007/s00467-021-05180-y
Askenazi DJ, Goldstein SL, Koralkar R, Fortenberry J, Baum M, Hackbarth R, Blowey D, Bunchman TE, Brophy PD, Symons J, Chua A, Flores F, Somers MJ (2013) Continuous renal replacement therapy for children </=10 kg: a report from the prospective pediatric continuous renal replacement therapy registry. J Pediatr 162:e583. https://doi.org/10.1016/j.jpeds.2012.08.044
Gonwa TA, Wadei HM (2012) The challenges of providing renal replacement therapy in decompensated liver cirrhosis. Blood Purif 33:144–148. https://doi.org/10.1159/000334149
Betrosian A-P, Agarwal B, Douzinas EE (2007) Acute renal dysfunction in liver diseases. World J Gastroenterol 13:5552–5559. https://doi.org/10.3748/wjg.v13.i42.5552
Agarwal B, Shaw S, Shankar Hari M, Burroughs AK, Davenport A (2009) Continuous renal replacement therapy (CRRT) in patients with liver disease: is circuit life different? J Hepatol 51:504–509. https://doi.org/10.1016/j.jhep.2009.05.028
Meier-Kriesche HU, Gitomer J, Finkel K, DuBose T (2001) Increased total to ionized calcium ratio during continuous venovenous hemodialysis with regional citrate anticoagulation. Crit Care Med 29:748–752. https://doi.org/10.1097/00003246-200104000-00010
Hendrix RJ, Hastings MC, Samarin M, Hudson JQ (2020) Predictors of hypophosphatemia and outcomes during Continuous Renal Replacement Therapy. Blood Purif 49:700–707. https://doi.org/10.1159/000507421
Hansen BA, Bruserud Ø (2018) Hypomagnesemia in critically ill patients. J Intensive Care 6:21. https://doi.org/10.1186/s40560-018-0291-y
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Cappoli, A., Labbadia, R., Antonucci, L. et al. A simplified protocol of regional citrate anticoagulation with phosphate-containing solutions in infants and children treated with continuous kidney replacement therapy. Pediatr Nephrol 38, 3835–3844 (2023). https://doi.org/10.1007/s00467-023-05994-y
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00467-023-05994-y